Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Golfert F et al. | 2001 | intact cell/cell culture, astrocytes (from neonatal rat brain) | magnetic field, 50/60 Hz, co-exposure | 100–200 µT |
Dibirdik I et al. | 2000 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) and NALM-6 cells (B cell precursor leukemia cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 100 µT |
Woods M et al. | 2000 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) and NALM-6 cells (B cell precursor leukemia cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 46–100 µT |
Nakasono S et al. | 2000 | bacterium, <i>Escherichia coli</i>/K12 | magnetic field, low frequency, 50/60 Hz, co-exposure | 7.8–14 mT |
Davies E et al. | 2000 | intact cell/cell culture, slime mold <i>Dictyostelium discoideum</i> | magnetic field, signals/pulses, 50/60 Hz, low frequency, therapeutic/medical device | 0.4–3 mT |
House RV et al. | 2000 | animal, mouse/B6C3F1, whole body | magnetic field, 50/60 Hz | 2 µT–1 mT |
Khadir R et al. | 1999 | intact cell/cell culture, neutrophils (from human venous blood) | magnetic field, 50/60 Hz, co-exposure | 0.1–44 mT |
Jandova A et al. | 1999 | intact cell/cell culture, human leucocytes (from venous blood of healthy humans and cancer patients) | magnetic field, 50/60 Hz | 1–10 mT |
Tao Q et al. | 1999 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
Pessina GP et al. | 1998 | intact cell/cell culture, peripheral blood mononuclear cells | magnetic field, signals/pulses, 50/60 Hz | 3 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.